News, Alerts, and Opinions

Headline Source Date
Puma Biotechnology Receives Results of CHMP Formal Decision for Neratinib for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer BusinessWire 07:30 AM EST
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results BusinessWire 02/15/18 EST
Puma Biotechnology to Present at LEERINK Partners Global Healthcare Conference BusinessWire 02/07/18 EST
Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Greater China BusinessWire 02/01/18 EST
Puma Biotechnology Announces Publication of Results from Phase II SUMMIT ‘Basket’ Trial Evaluating Neratinib in HER2 and HER3 Mutant Cancers BusinessWire 01/31/18 EST
Puma Biotechnology and Medison Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Israel BusinessWire 01/30/18 EST
Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) BusinessWire 01/29/18 EST
What's Happening With These Biotech Stocks? -- Novavax, Opko Health, Otonomy, and Puma Biotech PR Newswire 01/26/18 EST
42 Biggest Movers From Yesterday Benzinga 01/25/18 EST
Mid-Afternoon Market Update: Grainger Rises On Earnings Beat; Puma Biotechnology Shares Drop Benzinga 01/24/18 EST
32 Stocks Moving In Wednesday's Mid-Day Session Benzinga 01/24/18 EST
Mid-Day Market Update: NASDAQ Turns Lower; US Geothermal Shares Spike Higher Benzinga 01/24/18 EST
Mid-Morning Market Update: Markets Open Higher; United Technologies Tops Q4 Expectations Benzinga 01/24/18 EST
The Market In 5 Minutes: Border Wall, Allscripts Cyber Attack, Tesla's New Pay Plan Benzinga 01/24/18 EST
25 Stocks Moving In Wednesday's Pre-Market Session Benzinga 01/24/18 EST
Puma Biotech shares plummet after 'concerning turn' in Europe MarketWatch 01/24/18 EST